Matthew Townsend

4.9k total citations · 3 hit papers
23 papers, 4.0k citations indexed

About

Matthew Townsend is a scholar working on Cellular and Molecular Neuroscience, Physiology and Molecular Biology. According to data from OpenAlex, Matthew Townsend has authored 23 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 13 papers in Physiology and 11 papers in Molecular Biology. Recurrent topics in Matthew Townsend's work include Alzheimer's disease research and treatments (13 papers), Neuroscience and Neuropharmacology Research (10 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Matthew Townsend is often cited by papers focused on Alzheimer's disease research and treatments (13 papers), Neuroscience and Neuropharmacology Research (10 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Matthew Townsend collaborates with scholars based in United States, Ireland and Italy. Matthew Townsend's co-authors include Dennis J. Selkoe, Dominic M. Walsh, Ganesh M. Shankar, Bernardo L. Sabatini, Brenda L. Bloodgood, Weiqin Zhao, Martha Constantine‐Paton, Akira Yoshii, Pasko Rakić and Ezequiel Alvarez-Saavedra and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Neuron.

In The Last Decade

Matthew Townsend

23 papers receiving 4.0k citations

Hit Papers

Natural Oligomers of the Alzheimer Amyloid-β Protein Indu... 2004 2026 2011 2018 2007 2004 2006 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway
    2007 1.3k citations Ganesh M. Shankar, Brenda L. Bloodgood et al. Journal of Neuroscience profile →
  2. Microarray analysis of microRNA expression in the developing mammalian brain
    2004 652 citations Eric A. Miska, Ezequiel Alvarez-Saavedra et al. Genome biology profile →
  3. Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers
    2006 514 citations Matthew Townsend, Ganesh M. Shankar et al. The Journal of Physiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Townsend United States 18 2.5k 1.8k 1.5k 786 549 23 4.0k
Steffen Roßner Germany 35 2.6k 1.1× 2.0k 1.1× 1.4k 0.9× 840 1.1× 234 0.4× 114 4.9k
Russell E. Rydel United States 23 3.2k 1.3× 1.9k 1.0× 1.1k 0.8× 862 1.1× 234 0.4× 28 4.2k
Carlos A. Saura Spain 34 1.8k 0.7× 1.9k 1.1× 1.6k 1.1× 720 0.9× 150 0.3× 69 4.2k
Sarah L. Cole United States 12 3.1k 1.2× 1.6k 0.9× 1.1k 0.7× 814 1.0× 154 0.3× 14 4.5k
Martina K. Brückner Germany 33 1.5k 0.6× 1.6k 0.9× 961 0.7× 552 0.7× 180 0.3× 65 3.4k
Irina Rozovsky United States 25 3.5k 1.4× 2.7k 1.5× 1.4k 0.9× 744 0.9× 241 0.4× 31 6.3k
Bruno Vincent France 33 2.1k 0.8× 2.1k 1.2× 994 0.7× 573 0.7× 154 0.3× 70 4.2k
Yazi D. Ke Australia 28 2.6k 1.0× 1.6k 0.9× 1.4k 0.9× 610 0.8× 187 0.3× 57 4.2k
Sylvain Lesné United States 27 2.0k 0.8× 1.2k 0.7× 848 0.6× 540 0.7× 131 0.2× 38 3.1k
Takeshi Kawarabayashi Japan 31 4.1k 1.6× 2.2k 1.2× 1.3k 0.9× 889 1.1× 163 0.3× 129 5.7k

Countries citing papers authored by Matthew Townsend

Since Specialization
Citations

This map shows the geographic impact of Matthew Townsend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Townsend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Townsend more than expected).

Fields of papers citing papers by Matthew Townsend

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Townsend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Townsend. The network helps show where Matthew Townsend may publish in the future.

Co-authorship network of co-authors of Matthew Townsend

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Townsend. A scholar is included among the top collaborators of Matthew Townsend based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Townsend. Matthew Townsend is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mielich‐Süss, Benjamin, Lydia Reinhardt, Janina S. Ried, et al.. (2023). Establishment of a high-content imaging assay for tau aggregation in hiPSC-derived neurons differentiated from two protocols to routinely evaluate compounds and genetic perturbations. SLAS DISCOVERY. 29(2). 100137–100137. 1 indexed citations
3.
Amberg, Willi, J. van Bergeijk, Rui B. Chang, et al.. (2022). Pharmacological mTOR-inhibition facilitates clearance of AD-related tau aggregates in the mouse brain. European Journal of Pharmacology. 934. 175301–175301. 13 indexed citations
4.
Hu, Mufeng, Joseph A. Tamm, Yelena Y. Grinberg, et al.. (2021). Arrayed CRISPR reveals genetic regulators of tau aggregation, autophagy and mitochondria in Alzheimer’s disease model. Scientific Reports. 11(1). 2879–2879. 16 indexed citations
5.
Stoiljković, Milan, Liza Leventhal, Angela Chen, et al.. (2015). Concentration-response relationship of the α7 nicotinic acetylcholine receptor agonist FRM-17874 across multiple in vitro and in vivo assays. Biochemical Pharmacology. 97(4). 576–589. 24 indexed citations
6.
Grégoire, Laurent, et al.. (2013). Safinamide reduces dyskinesias and prolongs l-DOPA antiparkinsonian effect in parkinsonian monkeys. Parkinsonism & Related Disorders. 19(5). 508–514. 64 indexed citations
7.
Townsend, Matthew, Yujie Qu, Audrey Gray, et al.. (2010). Oral Treatment with a γ-Secretase Inhibitor Improves Long-Term Potentiation in a Mouse Model of Alzheimer's Disease. Journal of Pharmacology and Experimental Therapeutics. 333(1). 110–119. 35 indexed citations
8.
Zhao, Weiqin, Francesca Santini, Robert Breese, et al.. (2009). Inhibition of Calcineurin-mediated Endocytosis and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Prevents Amyloid β Oligomer-induced Synaptic Disruption. Journal of Biological Chemistry. 285(10). 7619–7632. 165 indexed citations
9.
Zhao, Weiqin & Matthew Townsend. (2008). Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1792(5). 482–496. 274 indexed citations
10.
Shankar, Ganesh M., Brenda L. Bloodgood, Matthew Townsend, et al.. (2007). Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway. Journal of Neuroscience. 27(11). 2866–2875. 1297 indexed citations breakdown →
11.
Townsend, Matthew, et al.. (2007). Soluble Aβ Inhibits Specific Signal Transduction Cascades Common to the Insulin Receptor Pathway. Journal of Biological Chemistry. 282(46). 33305–33312. 267 indexed citations
12.
Townsend, Matthew, et al.. (2006). Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers. The Journal of Physiology. 572(2). 477–492. 514 indexed citations breakdown →
13.
Townsend, Matthew, James Cleary, J. Hofmeister, et al.. (2006). Orally available compound prevents deficits in memory caused by the Alzheimer amyloid‐β oligomers. Annals of Neurology. 60(6). 668–676. 140 indexed citations
14.
Doench, John G., et al.. (2005). RNA interference of Xenopus NMDAR NR1 in vitro and in vivo. Journal of Neuroscience Methods. 152(1-2). 65–73. 12 indexed citations
15.
Walsh, Dominic M., Matthew Townsend, Marcia B. Podlisny, et al.. (2005). Certain Inhibitors of Synthetic Amyloid β-Peptide (Aβ) Fibrillogenesis Block Oligomerization of Natural Aβ and Thereby Rescue Long-Term Potentiation. Journal of Neuroscience. 25(10). 2455–2462. 248 indexed citations
16.
Townsend, Matthew, Yudong Liu, & Martha Constantine‐Paton. (2004). Retina-Driven Dephosphorylation of the NR2A Subunit Correlates with Faster NMDA Receptor Kinetics at Developing Retinocollicular Synapses. Journal of Neuroscience. 24(49). 11098–11107. 20 indexed citations
17.
Miska, Eric A., Ezequiel Alvarez-Saavedra, Matthew Townsend, et al.. (2004). Microarray analysis of microRNA expression in the developing mammalian brain. Genome biology. 5(9). 652 indexed citations breakdown →
18.
Townsend, Matthew, Akira Yoshii, Masayoshi Mishina, & Martha Constantine‐Paton. (2003). Developmental loss of miniature N -methyl- d -aspartate receptor currents in NR2A knockout mice. Proceedings of the National Academy of Sciences. 100(3). 1340–1345. 90 indexed citations
19.
Shi, Jian, Sandra Aamodt, Matthew Townsend, & Martha Constantine‐Paton. (2001). Developmental Depression of Glutamate Neurotransmission by Chronic Low-Level Activation of NMDA Receptors. Journal of Neuroscience. 21(16). 6233–6244. 32 indexed citations
20.
Shi, Jian, Matthew Townsend, & Martha Constantine‐Paton. (2000). Activity-Dependent Induction of Tonic Calcineurin Activity Mediates a Rapid Developmental Downregulation of NMDA Receptor Currents. Neuron. 28(1). 103–114. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steffen Roßner Breakdown of academic impact, for papers by Russell E. Rydel Breakdown of academic impact, for papers by Carlos A. Saura Breakdown of academic impact, for papers by Sarah L. Cole Breakdown of academic impact, for papers by Martina K. Brückner Breakdown of academic impact, for papers by Irina Rozovsky Breakdown of academic impact, for papers by Bruno Vincent Breakdown of academic impact, for papers by Yazi D. Ke Breakdown of academic impact, for papers by Sylvain Lesné Breakdown of academic impact, for papers by Takeshi Kawarabayashi
Rankless by CCL
2026